Watch the Video Interviews
Read more about Joseph and Nathan
The Talking Urology team discuss the Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer (CHAARTED6) trial with lead author Christopher Sweeney, who is a Medical Oncologist at the Dana-Farber Cancer Institute, Boston, USA.
His primary research interest is drug discovery and development with an academic focus on the management of genitourinary malignancies, in particular prostate and testicular cancer.
Stay up-to-date to receive content updates on the Talking Urology Podcast Series.